|
|
|
|
Gerresheimer AG
|
|
Syringe siliconization
|
|
Ready-to-fill, i.e. sterile, prefillable glass syringes, are washed,
siliconized, sterilized and packaged by the primary packaging
manufacturer. They can then be filled by the pharmaceutical companies
without any further processing. These days the majority of prefillable
syringes are made of glass and the trend looks set to continue. The
siliconization of the syringe barrel is an extremely important aspect of
the production of sterile, prefillable glass syringes because the
functional interaction of the glass barrel siliconization and the
plunger stopper siliconization is crucial to the efficiency of the
entire system. Both inadequate and excessive siliconization can cause
problems in this connection. The use of modern technology can achieve an
extremely uniform distribution of silicone oil in glass syringes with
reduced quantities of silicone oil. Another option for minimizing the
amount of free silicone oil in a syringe is the thermal fixation of the
silicone oil on the glass surface in a process called baked-on
siliconization. Plastic-based silicone oil-free or low-silicone oil
prefillable syringe systems are a relatively new development. Silicone
oil-free lubricant coatings for syringes are also currently in the
development phase.
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Protagen Protein Services and BioAnalytix Merge to Create Global Analytic Service Partner for Biopharmaceuticals
Protagen Protein Services GmbH (PPS), a full-service contract research organization (CRO) in protein analytics and BioAnalytix Inc., a Cambridge (MA)-based specialized provider of advanced analytics in biopharmaceutical development announced today a merger that will
transform the combined company into a leading global analytic services
provider for the biopharmaceutical industry. Today’s announcement
creates a best-in-class partner for biopharmaceutical companies
worldwide to benefit from the most advanced, integrated and complete
analytic services capabilities in biopharmaceutical development, from
clone selection through drug approval to commercialization.
More info >> |
|
 |
White Papers |
 |
|
Clinical Trials in Ukraine: Orange Paper Overview and 1st Half Year 2014
Synergy Research Group
The Orange Paper is an analytical report about the clinical trials
market in Russia, published quarterly by the contract research
organization Synergy Research Group. The first edition of Orange Paper
was released in 2006, and at the moment 31 issues have already
published. Now, thanks to Synergy Group Ukraine, obtaining information
about the market of clinical trials in Ukraine has become possible.
In
Ukraine, during the period from 1996 to 2013, applicants had obtained
3,864 positive conclusions about the possibility of conducting clinical
trials of drugs, both for domestic and foreign manufacturers, including
conduct of multinational multi-center clinical trials (hereinafter –
MMCTs)
More info >> |
|
 |
Industry Events |
 |
ASGCT 22nd Annual Meeting
29 April - 2 May 2019, Washington Hilton, Washington, D.C
The 2019 ASGCT Annual Meeting is expected to be the largest in Society
history, eclipsing the mark set by the 2018 meeting just last year. Join more
than 3,500 researchers, clinicians, advocates, and industry leaders in
discovering the latest science and technology surrounding gene and cell
therapy.
More info >> |
|
|
|
